Related Experiment Video
Updated: Jan 28, 2026

Transient Transduction of the Strobilated Forms of Echinococcus granulosus
Published on: September 16, 2022
In Vitro and in Vivo Effect of MAPK Signal Transduction Pathway Inhibitors on Echinococcus multilocularis
Wei-Feng Gui1, Shuo Xu1, Zhi-Sheng Dang2
11 Department of Parasitology, School of Basic Medicine, Guilin Medical University, Guilin, Guangxi 541004, People's Republic of China.
Abstract:
To evaluate the effect of mitogen-activated protein kinase (MAPK) signal transduction pathway inhibitors against alveolar echinococcosis in vitro and in vivo, Echinococcus multilocularis metacestode cysts and protoscolices were obtained from infected mice. Protein chip technology was utilized to screen for key highly expressed target proteins in the MAPK pathway in this parasite and their corresponding inhibitors. Four-week-old Balb/c female mice used for the in vivo experiment underwent inoculation of E. multilocularis by intraperitoneal injection, as well as intragastric administration of MAPK inhibitors for 6 wk. We included 6 groups of mice: a phosphate-buffered saline (PBS) group (negative control); an albendazole-treated group (positive group); and 4 experimental groups treated with TRx0237 mesylate, GDC-0994, pifithrin-β hydrobromide, or Selonsertib. Echinococcus multilocularis protoscolices were collected and cultured in 1066 medium with penicillin/streptomycin and 10% fetal bovine serum. The in vitro experiment included a PBS group (negative control), a dimethyl sulfoxide-treated group (solvent group), and 4 inhibitor-treated groups as in the in vivo experiment (experimental groups). Each inhibitor group received 4 drug concentrations (5, 30, 55, and 80 μM), and the experiment was performed in triplicate per sample. Fluorescence microscopy was used to evaluate the survival rate of the protoscolices every 48 hr beginning from the first 24 hr. The same grouping was used to evaluate cytotoxicity on E. multilocularis germinal cells and L02 cells. The average weights of E. multilocularis metacestode cyst tissue from each group of the in vivo experiment were 873 mg (PBS), 335 mg (albendazole), 323 mg (TRx0237 mesylate), 420 mg (GDC-0994), 340 mg (pifithrin-β hydrobromide), and 642 mg (Selonsertib). Results showed albendazole, TRx0237 mesylate, and pifithrin-β hydrobromide had significant inhibitory effects on inhibition of E. multilocularis. We found a positive correlation between drug concentrations and the inhibitory effects seen in the in vitro experiment, with the differences in contrast with the control group becoming statistically significant after 72 hr of treatment ( P < 0.05). The inhibition rates of TRx0237 mesylate to germinal cells by drug concentration were 23.73, 46.59, 74.71, and 77.44%. Other drugs had no effect on germinal cells. All the inhibitors had low toxicity on L02 cells. Inhibitors of the MAPK signal transduction pathway showed significant inhibitory effects on E. multilocularis, suggesting these may be potential candidates for the treatment of alveolar echinococcosis.
Insights
Mitogen-activated protein kinase (MAPK) pathway inhibitors show promise for treating alveolar echinococcosis. TRx0237 mesylate and pifithrin-β hydrobromide effectively inhibited Echinococcus multilocularis growth in vitro and in vivo.
Area of Science:
- Parasitology
- Molecular Biology
- Pharmacology
Background:
- Alveolar echinococcosis is a severe parasitic disease caused by Echinococcus multilocularis.
- Current treatments have limitations, necessitating the exploration of novel therapeutic targets.
- The mitogen-activated protein kinase (MAPK) signaling pathway is crucial for parasite survival and proliferation.
Purpose of the Study:
- To investigate the efficacy of MAPK signal transduction pathway inhibitors against Echinococcus multilocularis.
- To evaluate the in vitro and in vivo effects of selected MAPK inhibitors on E. multilocularis.
- To identify potential new drug candidates for alveolar echinococcosis treatment.
Main Methods:
- Echinococcus multilocularis metacestode cysts and protoscolices were obtained from infected mice.
- Protein chip technology was used to screen for highly expressed MAPK pathway targets and inhibitors.
- In vivo studies involved treating infected mice with MAPK inhibitors (TRx0237 mesylate, GDC-0994, pifithrin-β hydrobromide, Selonsertib) or albendazole for 6 weeks.
- In vitro studies assessed protoscolex viability, germinal cell cytotoxicity, and L02 cell toxicity across various drug concentrations.
Main Results:
- Albendazole, TRx0237 mesylate, and pifithrin-β hydrobromide demonstrated significant inhibitory effects on E. multilocularis in vivo.
- In vitro experiments showed a dose-dependent inhibition of protoscolex viability by TRx0237 mesylate and pifithrin-β hydrobromide, with significant effects observed after 72 hours.
- TRx0237 mesylate exhibited concentration-dependent inhibition of germinal cells, while other tested drugs showed minimal impact on parasite cells and low toxicity to host L02 cells.
Conclusions:
- Inhibitors targeting the MAPK signal transduction pathway exhibit significant anti-parasitic activity against Echinococcus multilocularis.
- TRx0237 mesylate and pifithrin-β hydrobromide are identified as promising candidates for further development in treating alveolar echinococcosis.
- MAPK pathway inhibition represents a viable therapeutic strategy for combating alveolar echinococcosis.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
08:54Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
Related Concept Videos
MAPK Signaling Cascades
Signal Transduction: Overview
Typically, signal transduction involves three...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways